Management of hemoptysis in patients with cystic fibrosis: Summary of consensus statement

	Scant	Mild or moderate	Massive
Systemic antibiotics	Depends on other features*	Start	Start
NSAIDs	Stop	Stop	Stop
Airway clearance techniques (eg, chest physiotherapy)	Continue	No consensus^¶	Stop
Aerosol therapies
Hypertonic saline	Continue	Stop^Δ	Stop
Dornase alpha	Continue	No consensus	No consensus
Antibiotics	Continue	Continue^Δ	Continue^◊
Bronchodilators	Continue	Continue^Δ	Continue^◊

This table summarizes the conclusions of a consensus panel convened by the Cystic Fibrosis Foundation's Pulmonary Therapies Committee.

NSAIDs: nonsteroidal antiinflammatory drugs.

* For scant hemoptysis, the panel recommended starting systemic antibiotics if the patient has any other features of an acute exacerbation or if the hemoptysis is progressive.

¶ No good consensus was reached for this issue.

Δ Consensus for this recommendation was good but with some reservations and considerations specific to the individual patient.

◊ No good consensus was reached for this issue, but the panel felt that benefits of continuing often outweigh the risks.

Data from: Flume PA, Mogayzel PJ Jr, Robinson KA, et al. Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. Am J Respir Crit Care Med 2010; 182:298.

Graphic 97388 Version 4.0

خرید پکیج

Management of hemoptysis in patients with cystic fibrosis: Summary of consensus statement